Butler J, Anker SD, Filippatos G, Khan MS, et al. Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial. Eur Heart J 2021 Jan 9. pii: 6072066. doi: 10.1093/eurheartj/ehaa1007.
PMID: 33420498